VAERS reports by lot

GSK Hepatitis B lot 2KE55: VAERS reports

46 VAERS reports list lot 2KE55 as a GSK Hepatitis B vaccine, received between 2022-08-27 and 2024-04-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
46
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)619%
Neurological516%
Musculoskeletal516%
Respiratory310%
Injection-site / Local reaction310%
Cardiac / Cardiovascular26%
Allergic / Anaphylactic26%
Gastrointestinal26%
Dermatological (non-injection-site)26%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Texas5
California3
Kentucky3
Missouri3
Indiana2
Oklahoma2
Ohio2
Massachusetts2
Utah1
South Carolina1
Louisiana1

Reports by month received

2022-081
2022-091
2022-103
2022-112
2022-122
2023-013
2023-032
2023-054
2023-062
2023-071
2023-081
2023-1015
2023-113
2023-123
2024-021
2024-031
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.